TY  - GEN
AU  - Kjersem,Janne B
AU  - Skovlund,Eva
AU  - Ikdahl,Tone
AU  - Guren,Tormod
AU  - Kersten,Christian
AU  - Dalsgaard,Astrid M
AU  - Yilmaz,Mette K
AU  - Fokstuen,Tone
AU  - Tveit,Kjell M
AU  - Kure,Elin H
TI  - FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab
SN  - 1471-2407
PY  - 2015///0224
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Cetuximab
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Leucovorin
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Polymorphism, Single Nucleotide
KW  - Proportional Hazards Models
KW  - Proto-Oncogene Proteins
KW  - genetics
KW  - Proto-Oncogene Proteins p21(ras)
KW  - Receptors, IgG
KW  - Time Factors
KW  - Treatment Outcome
KW  - Young Adult
KW  - ras Proteins
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1471-2407-14-340
ER  -